Skip to content

Exploratory Study on the Application of Thoracoabdominal Endoscopic Surgical System in 5G Remote Surgery for Urological Treatment

Exploratory Study on the Application of Thoracoabdominal Endoscopic Surgical System in 5G Remote Surgery for Urological Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100456
Enrollment
Unknown
Registered
2025-04-09
Start date
2025-04-10
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary System Tumors

Interventions

Intervention Group:5G remote surgery was completed on subjects using a thoracic and abdominal endoscopic surgical system

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. 18 years old< = actual age< = 80 years old; 2. Patients with urinary tract tumors confirmed by clinical examination, with indications for laparoscopic surgical treatment and no obvious contraindications to surgery; 3. It is planned to undergo 5G remote surgical treatment in the thoracic and abdominal endoscopic surgery system; 4. Voluntarily participate in this study and sign the informed consent form in writing.

Exclusion criteria

Exclusion criteria: 1. Those with clinical stage IV of malignant tumors; 2. Received abdominopelvic radiotherapy before surgery; 3. Active bleeding, severe abnormal coagulation function (prothrombin time (PT) or international normalized ratio (INR) is higher than 1.5 times the upper limit of normal) or platelet count < 80×10^9/L; 4. Have severe cardiovascular, cerebrovascular or respiratory diseases and cannot tolerate surgery; 5. Participated in other clinical trials in the past 1 month; 6. Inability to understand the requirements of the trial, or unable to complete the study follow-up plan; 7. Other conditions that are considered by the investigator to be unsuitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Comlications;

Secondary

MeasureTime frame
Success of the surgery;Intraoperative blood loss;Duration of surgery;Postoperative drain indwelling time;Postoperative urinary catheter indwelling time;Pathological specimens sent for testing;

Countries

China

Contacts

Public ContactLiu Ming

Beijing Hospital

liuming19731029@163.com+86 10 85136271

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026